Myshliakova N V, Auna Z P, Indulen Iu I, Klusha V E, Chipens G I
Probl Endokrinol (Mosk). 1976 May-Jun;22(3):85-9.
The authors studied comparatively the properties of two angiotensin II analogues, a new compound (1-hydantoin acid, 5-valine, 8-alanine)-angiotensin II (compound III) and (1-asparagine, 5-valine, 8-alanine)-angiotensin II (compound II), as of the myotropic action of angiotensinamide (these experiments were conducted on the rat isolated ascending colon); pressor action of the hormone was investigated in experiments on anesthetized rats. A competitive character of the antagonism--within the range of low concentrations of the analogues--10(-10)--10(-9) M/l--was revealed in vitro. No antagonism was expressed against the nonspecific myotropic agents--acetylcholine and bradykinin. In vivo compounds II and II manifested the antagonistic action against angiotensinamide beginning from the doses of 100 and 50 gamma/kg, respectively.
作者比较研究了两种血管紧张素II类似物的性质,一种新化合物(1-乙内酰脲酸,5-缬氨酸,8-丙氨酸)-血管紧张素II(化合物III)和(1-天冬酰胺,5-缬氨酸,8-丙氨酸)-血管紧张素II(化合物II),就血管紧张素酰胺的肌动作用而言(这些实验是在大鼠离体升结肠上进行的);在麻醉大鼠实验中研究了该激素的升压作用。在体外揭示了拮抗剂的竞争性特征——在低浓度类似物范围内——10(-10)——10(-9)M/升。对非特异性肌动剂——乙酰胆碱和缓激肽没有拮抗作用。在体内,化合物II和III分别从100和50微克/千克的剂量开始表现出对血管紧张素酰胺的拮抗作用。